Adrenal Glands pp 101-113 | Cite as

Classic Congenital Adrenal Hyperplasia

  • Evangelia Charmandari
  • George Chrousos
  • Deborah P. Merke


Congenital Adrenal Hyperplasia Corticotropin Release Hormone Adrenal Androgen Classic Congenital Adrenal Hyperplasia Plasma Free Metanephrine 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Speiser PW, White PC (2003) Congenital adrenal hyperplasia. N Engl J Med 349:776–88CrossRefPubMedGoogle Scholar
  2. 2.
    Merke DP, Bornstein SR, Avila NA, Chrousos GP (2002) NIH conference. Future directions in the study and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Ann Intern Med 136:320–34PubMedGoogle Scholar
  3. 3.
    Merke DP, Cutler GB Jr (2001) New ideas for medical treatment of congenital adrenal hyperplasia. Endocrinol Metab Clin North Am 30:121–35PubMedGoogle Scholar
  4. 4.
    White PC, Speiser PW (2000) Congenital adrenal hyper-plasia due to 21-hydroxylase deficiency. Endocr Rev 21: 245–91Google Scholar
  5. 5.
    Newfield RS, New MI (1997) 21-Hydroxylase deficiency. Ann N Y Acad Sci 816:219–29PubMedGoogle Scholar
  6. 6.
    Therrell BL (2001) Newborn screening for congenital adrenal hyperplasia. Endocrinol Metab Clin North Am 30: 15–30PubMedGoogle Scholar
  7. 7.
    Speiser PW, Dupont B, Rubinstein P, Piazza A, Kastelan A, New MI (1985) High frequency of nonclassical steroid 21-hydroxylase deficiency. Am J Hum Genet 37:650–667PubMedGoogle Scholar
  8. 8.
    Prader A (1954) Der Genitalbefund beim Pseudoher-maphroditismus Femininus der kengenitalen andreno-genitalen Syndroms. Helv Paediatr Acta 9:231–248PubMedGoogle Scholar
  9. 9.
    Oelkers WK (1996) Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure. Steroids 61:166–171CrossRefPubMedGoogle Scholar
  10. 10.
    Merke DP, Chrousos GP, Eisenhofer G, Weise M, Keil MF, Rogol AD, Van Wyk JJ, Bornstein SR (2000) Adreno-medullary dysplasia and hypofunction in patients with classic 21-hydroxylase deficiency. N Engl J Med 343: 1362–1368CrossRefPubMedGoogle Scholar
  11. 11.
    Jaaskelainen J, Voutilainen R (1997) Growth of patients with 21-hydroxylase deficiency: an analysis of the factors influencing adult height. Pediatr Res 41:30–33PubMedGoogle Scholar
  12. 12.
    New MI, Gertner GM, Speiser PW, del Balzo P (1988) Growth and final height in classical and nonclassical 21-hydroxylase deficiency. Acta Paediatr Jpn 30[Suppl]: 79–88PubMedGoogle Scholar
  13. 13.
    Eugster EA, Dimeglio LA, Wright JC, Freidenberg GR, Seshadri R, Pescovitz OH (2001) Height outcome in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency: a meta-analysis. J Pediatr 138:26–32CrossRefPubMedGoogle Scholar
  14. 14.
    Yu AC, Grant DB (1995) Adult height in women with early-treated congenital adrenal hyperplasia (21-hydroxylase type): relation to body mass index in earlier childhood. Acta Paediatr 84:899–903PubMedGoogle Scholar
  15. 15.
    Barnes RB, Rosenfield RL, Ehrmann DA, Cara JF, Cuttler L, Levitsky LL, Rosenthal IM (1994) Ovarian hyper-androgynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women. J Clin Endocrinol Metab 79:1328–33CrossRefPubMedGoogle Scholar
  16. 16.
    Helleday J, Siwers B, Ritzen EM, Carlstrom K (1993) Subnormal androgen and elevated progesterone levels in women treated for congenital virilizing 21-hydroxylase deficiency. J Clin Endocrinol Metab 76:933–936CrossRefPubMedGoogle Scholar
  17. 17.
    London DR (1987) The consequences of hyperandrogenism in young women. J R Soc Med 80:741–745PubMedGoogle Scholar
  18. 18.
    Azziz R, Mulaikal RM, Migeon CJ, Jones HW, Rock JA (1986) Congenital adrenal hyperplasia: long term results following vaginal reconstruction. Fertil Steril 46:1011–1014PubMedGoogle Scholar
  19. 19.
    Kuhnle U, Bullinger M, Schwarz HP, Knorr D (1993) Part-nership and sexuality in adult female patients with congenital adrenal hyperplasia. First results of a cross-sectional quality — of — life evaluation. J Steroid Biochem 45:123–126CrossRefGoogle Scholar
  20. 20.
    Kuhnle U, Bullinger M, Schwarz HP (1995) The quality of life in adult female patients with congenital adrenal hyperplasia: a comprehensive study of the impact of genital malformations and chronic disease on female patients’ life. Eur J Pediatr 154:708–716PubMedGoogle Scholar
  21. 21.
    Lo JC, Grumbach MM (2001) Pregnancy outcomes in women with congenital virilizing adrenal hyperplasia. Endocrinol Metab Clin North Am 30:207–229PubMedGoogle Scholar
  22. 22.
    Premawardhana LD, Hughes IA, Read GF, Scanlon MF (1997) Longer term outcome in females with congenital adrenal hyperplasia (CAH): the Cardiff experience. Clin Endocrinol (Oxf) 46:327–332CrossRefGoogle Scholar
  23. 23.
    Stikkelbroeck NM, Otten BJ, Pasic A, Jager GJ, Sweep CG, Noordam K, Hermus AR (2001) High prevalence of testicular adrenal rest tumors, impaired spermatogenesis, and Leydig cell failure in adolescent and adult males with congenital adrenal hyperplasia. J Clin Endocrinol Metab 86:5721–8CrossRefPubMedGoogle Scholar
  24. 24.
    Clayton PE, Miller WL, Oberfield SE, Ritzen EM, Sippell WG, Speiser PW (2002) Consensus Statement on 21-Hydroxylase Deficiency from The Lawson Wilkins Pediatric Endocrine Society and The European Society for Paediatric Endocrinology. J Clin Endocrinol Metab 87:4048–4053CrossRefPubMedGoogle Scholar
  25. 25.
    Fedderman DD (1987) Psychosexual adjustment in congenital adrenal hyperplasia. N Engl J Med 316:209–211PubMedGoogle Scholar
  26. 26.
    Dittmann RW, Kappes M, Kappes ME, Berger D, Stegner H, Willig Rh, Wallis H (1990) Congenital adrenal hyperplasia I: gender-related behavior and attitudes in female patients and sisters. Psychoendocrinology 15:401–420; 421–434CrossRefGoogle Scholar
  27. 27.
    Berenbaum SA, Duck SC, Bryk K (2000) Behavioral effects of prenatal versus postnatal androgen excess in children with 21-hydroxylase-deficient congenital adrenal hyperplasia. J Clin Endocrinol Metab 85:727–33CrossRefPubMedGoogle Scholar
  28. 28.
    Dittmann RW, Kappes ME, Kappes MH (1992) Sexual behavior in adolescent and adult females with congenital adrenal hyperplasia. Psychoneuroendocrinology 17:153–70CrossRefPubMedGoogle Scholar
  29. 29.
    Zucker KJ, Bradley SJ, Oliver G, Blake J, Fleming S, Hood J (1996) Psychosexual development of women with congenital adrenal hyperplasia. Horm Behav 30:300–18CrossRefPubMedGoogle Scholar
  30. 30.
    Meyer-Bahlburg HF (2001) Gender and sexuality in classic congenital adrenal hyperplasia. Endocrinol Metab Clin North Am 30:155–71PubMedGoogle Scholar
  31. 31.
    Jaresch S, Kornely E, Kley HK, Schlaghecke R (1992) Adrenal incidentaloma and patients with homozygous and heterozygous congenital adrenal hyperplasia. J Clin Endocrinol Metab 74:685–689CrossRefPubMedGoogle Scholar
  32. 32.
    Lightner ES, Levine LS (1993) The adrenal incidentaloma. A pediatric perspective. Am J Dis Child 147: 1274–1276PubMedGoogle Scholar
  33. 33.
    Cabrera MS, Vogiatzi MG, New MI (2001) Long term outcome in adult males with classic congenital adrenal hyperplasia. J Clin Endocrinol Metab 86:3070–3078PubMedGoogle Scholar
  34. 34.
    Avila NA, Premkumar A, Merke DP (1999) Testicular adrenal rest tissue in congenital adrenal hyperplasia: comparison of MR imaging and sonographic findings. AJR Am J Roentgenol 172:1003–6PubMedGoogle Scholar
  35. 35.
    Srikanth MS, West BR, Ishitani M, Isaacs H Jr, Applebaum H, Costin G (1992) Benign testicular tumors in children with congenital adrenal hyperplasia. J Pediatr Surg 27: 639–641CrossRefPubMedGoogle Scholar
  36. 36.
    Avila NA, Premkumar A, Shawker TH, Jones JV, Laue L, Cutler GB Jr (1996) Testicular adrenal rest tissue in congenital adrenal hyperplasia: findings at Gray-scale and color Doppler US. Radiology 198:99–104PubMedGoogle Scholar
  37. 37.
    Walker BR, Skoog SJ, Winslow BH, Canning DA, Tank ES (1997) Testis sparing surgery for steroid unresponsive testicular tumors of the adrenogenital syndrome. J Urol 157:1460–1463CrossRefPubMedGoogle Scholar
  38. 38.
    Speiser PW, Heier L, Serrat J, New MI, Nass R (1995) Failure of steroid replacement to consistently normalize pituitary function in congenital adrenal hyperplasia: hormonal and MRI data. Horm Res 44:241–246PubMedGoogle Scholar
  39. 39.
    Moran C, Azziz R, Carmina E, Dewailly D, Fruzzetti F, Ibanez L, Knochenhauer ES, Marcondes JA, Mendonca BB, Pignatelli D, Pugeat M, Rohmer V, Speiser PW, Witchel SF (2000) 21-Hydroxylase-deficient nonclassical adrenal hyperplasia is a progressive disorder: a multicenter study. Am J Obstet Gynecol 183:1468–1474CrossRefPubMedGoogle Scholar
  40. 40.
    Grumbach MM, Conte FA (1998) Disorders of sex differentiation. In: Wilson JD, Foster DW, Kronenberg HM, Larsen PR (eds) Williams textbook of endocrinology. WB Saunders, Philadelphia, pp 1303–1426Google Scholar
  41. 41.
    Nomura S (1997) Immature adrenal steroidogenesis in preterm infants. Early Hum Dev 49:225–233CrossRefPubMedGoogle Scholar
  42. 42.
    Brosnan PG, Brosnan CA, Kemp SF, Domek DB, Jelley DH, Blackett PR, Riley WJ (1999) Effect of newborn screening for congenital adrenal hyperplasia. Acta Pediatr Adolesc Med 153:1272–1278Google Scholar
  43. 43.
    Thompson R, Seargeant L, Winter JS (1989) Screening for congenital adrenal hyperplasia: distribution of 17α-hydroxyprogesterone concentrations in neonatal blood spot specimens. J Pediatr 114:400–404PubMedGoogle Scholar
  44. 44.
    Thilen A, Larsson A (1990) Congenital adrenal hyperplasia in Sweden 1969–1986. Prevalence, symptoms and age at diagnosis. Acta Pediatr Scand 79:168–175Google Scholar
  45. 45.
    Balsamo A, Cacciari E, Piazzi S, Cassio A, Bozza A, Pirazzoli P, Zappula F (1996) Congenital adrenal hyperplasia: neonatal mass screening with clinical diagnosis only in the Emilia-Romagna region of Italy, 1980–1995. Pediatrics 98:362–367PubMedGoogle Scholar
  46. 46.
    New MI, Lorenzen F, Lerner AJ, Kohn B, Oberfield SE, Pollack MS, Dupont B, Stoner E, Levy DJ, Pang S, Levine LS (1983) Genotyping steroid 21-hydroxylase deficiency: hormonal reference data. J Clin Endocrinol Metab 57: 320–326PubMedGoogle Scholar
  47. 47.
    Fiet J, Gueux B, Gourmelen M, Kuttenn F, Vexiau P, Couillin P, Pham-Huu-Trung MT, Villette JM, Raux-Demay MC, Galons H, et al. (1988) Comparison of basal and adrenocorticotropin-stimulated plasma 21-deoxycortisol and 17-hydroxyprogesterone values as biological markers of late-onset adrenal hyperplasia. J Clin Endocrinol Metab 66:659–667PubMedGoogle Scholar
  48. 48.
    Honour JW (1997) Steroid profiling. Ann Clin Biochem 34:32–44PubMedGoogle Scholar
  49. 49.
    Honour JW, Brook CGD (1997) Clinical indications for the use of urinary steroid profiles in neonates and children. Ann Clin Biochem 34:45–54PubMedGoogle Scholar
  50. 50.
    Carroll MC, Campbell RD, Porter RR (1985) Mapping of steroid 21-hydroxylase genes adjacent to complement component C4 genes in HLA, the major histocompatibility complex in man. Proc Natl Acad Sci USA 82: 521–5PubMedGoogle Scholar
  51. 51.
    Higashi Y, Yoshioka H, Yamane M, Gotoh O, Fujii-Kuriyama Y (1986) Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: a pseudogene and a genuine gene. Proc Natl Acad Sci USA 83:2841–5PubMedGoogle Scholar
  52. 52.
    White PC, New MI, Dupont B (1986) Structure of human steroid 21-hydroxylase genes. Proc Natl Acad Sci USA 83:5111–5PubMedGoogle Scholar
  53. 53.
    White PC, Tusie-Luna MT, New MI, Speiser PW (1994) Mutations in steroid 21-hydroxylase (CYP21). Hum Mutat 3:373–8PubMedGoogle Scholar
  54. 54.
    White PC, Vitek A, Dupont B, New MI (1988) Characterization of frequent deletions causing steroid 21-hydroxylase deficiency. Proc Natl Acad Sci USA 85:4436–40PubMedGoogle Scholar
  55. 55.
    Higashi Y, Tanae A, Inoue H, Fujii-Kuriyama Y (1988) Evidence for frequent gene conversion in the steroid 21-hydroxylase P-450(C21) gene: implications for steroid 21-hydroxylase deficiency. Am J Hum Genet 42:17–25PubMedGoogle Scholar
  56. 56.
    Speiser PW, Dupont J, Zhu D, Serrat J, Buegeleisen M, Tusie-Luna MT, Lesser M, New MI, White PC (1992) Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Invest 90:584–595PubMedGoogle Scholar
  57. 57.
    Higashi Y, Hiromasa T, Tanae A, Miki T, Nakura J, Kondo T, Ohura T, Ogawa E, Nakayama K, Fujii-Kuriyama Y (1991) Effects of individual mutations in the P-450(C21) pseudogene on the P-450(C21) activity and their distribution in the patient genomes of congenital steroid 21-hydroxylase deficiency. J Biochem (Tokyo) 109:638–44PubMedGoogle Scholar
  58. 58.
    Tusie-Luna MT, Speiser PW, Dumic M, New MI, White PC (1991) A mutation (Pro-30 to Leu) in CYP21 represents a potential nonclassic steroid 21-hydroxylase deficiency allele. Mol Endocrinol 5:685–692PubMedGoogle Scholar
  59. 59.
    Speiser PW, New MI (1987) Genotype and hormonal phenotype in nonclassical 21-hydroxylase deficiency. J Clin Endocrinol Metab 64:86–91PubMedGoogle Scholar
  60. 60.
    Wedell A, Thilen A, Ritzen EM, Stengler B, Luthman H (1994) Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: implications for genetic diagnosis and association with disease manifestation. J Clin Endocrinol Metab 78:1145–52CrossRefPubMedGoogle Scholar
  61. 61.
    Wilson RC, Mercado AB, Cheng KC, New MI (1995) Steroid 21-hydroxylase deficiency: genotype may not predict phenotype. J Clin Endocrinol Metab 80:2322–9CrossRefPubMedGoogle Scholar
  62. 62.
    Jaaskelainen J, Levo A, Voutilainen R, Partanen J (1997) Population-wide evaluation of disease manifestation in relation to molecular genotype in steroid 21-hydroxylase (CYP21) deficiency: good correlation in a well defined population. J Clin Endocrinol Metab 82:3293–7CrossRefPubMedGoogle Scholar
  63. 63.
    Krone N, Braun A, Roscher AA, Knorr D, Schwarz HP (2000) Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany. J Clin Endocrinol Metab 85:1059–65CrossRefPubMedGoogle Scholar
  64. 64.
    Deneux C, Tardy V, Dib A, Mornet E, Billaud L, Charron D, Morel Y, Kuttenn F (2001) Phenotype-genotype correlation in 56 women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 86:207–13CrossRefPubMedGoogle Scholar
  65. 65.
    Winkel CA, Casey ML, Worley RJ, Madden JD, MacDonald PC (1983) Extraadrenal steroid 21-hydroxylase activity in a woman with congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency. J Clin Endocrinol Metab 56:104–7PubMedGoogle Scholar
  66. 66.
    Mellon SH, Miller WL (1989) Extraadrenal steroid 21-hydroxylation is not mediated by P450c21. J Clin Invest 84:1497–502PubMedGoogle Scholar
  67. 67.
    Zhou Z, Agarwal VR, Dixit N, White P, Speiser PW (1997) Steroid 21-hydroxylase expression and activity in human lymphocytes. Mol Cell Endocrinol 127:11–18CrossRefPubMedGoogle Scholar
  68. 68.
    Charmandari E, Eisenhofer G, Mehlinger SL, Carlson A, Wesley R, Keil MF, Chrousos GP, New MI, Merke DP (2002) Adrenomedullary function may predict phenotype and genotype in classic 21-hydroxylase deficiency. J Clin Endocrinol Metab 87:3031–7CrossRefPubMedGoogle Scholar
  69. 69.
    Charmandari E, Hindmarsh PC, Johnston A, Brook CG (2001) Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: alterations in cortisol pharmacokinetics at puberty. J Clin Endocrinol Metab 86:2701–8CrossRefPubMedGoogle Scholar
  70. 70.
    Charmandari E, Johnston A, Brook CG, Hindmarsh PC (2001) Bioavailability of oral hydrocortisone in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Endocrinol 169:65–70CrossRefPubMedGoogle Scholar
  71. 71.
    Kerrigan JR, Veldhuis JD, Leyo SA, Iranmanesh A, Rogol AD (1993) Estimation of daily cortisol production and clearance rates in normal pubertal males by deconvolution analysis. J Clin Endocrinol Metab 76:1505–1510CrossRefPubMedGoogle Scholar
  72. 72.
    Charmandari E, Matthews DR, Johnston A, Brook CG, Hindmarsh PC (2001) Serum cortisol and 17-hydroxy-progesterone interrelation in classic 21-hydroxylase deficiency: is current replacement therapy satisfactory? J Clin Endocrinol Metab 86:4679–85CrossRefPubMedGoogle Scholar
  73. 73.
    Lamberts SW, Bruining HA, De Jong FH (1997) Cortico-steroid therapy in severe illness. N Engl J Med 337: 1285–1292CrossRefPubMedGoogle Scholar
  74. 74.
    Charmandari E, Lichtarowicz-Krynska EJ, Hindmarsh PC, Johnston A, Aynsley-Green A, Brook CG (2001) Congenital adrenal hyperplasia: management during critical illness. Arch Dis Child 85:26–8CrossRefPubMedGoogle Scholar
  75. 75.
    Van Wyk JJ, Gunther DF, Ritzen EM, Wedell A, Cutler GB Jr, Migeon CJ, New MI (1996) The use of adrenalectomy as a treatment for congenital adrenal hyperplasia. J Clin Endocrinol Metab 81:3180–3190CrossRefPubMedGoogle Scholar
  76. 76.
    Tajima T, Ma XM, Bornstein SR, Aguilera G (1999) Prenatal dexamethasone treatment does not prevent alterations of the hypothalamic pituitary adrenal axis in steroid 21-hydroxylase deficient mice. Endocrinology 140:3354–62CrossRefPubMedGoogle Scholar
  77. 77.
    Merke DP, Keil MF, Jones JV, Fields J, Hill S, Cutler GB Jr (2000) Flutamide, testolactone, and reduced hydrocortisone dose maintain normal growth velocity and bone maturation despite elevated androgen levels in children with congenital adrenal hyperplasia. J Clin Endocrinol Metab 85:1114–20CrossRefPubMedGoogle Scholar
  78. 78.
    Grammatopoulos DK, Chrousos GP (2002) Functional characteristics of CRH receptors and potential clinical applications of CRH-receptor antagonists. Trends Endocrinol Metab 13:436–44CrossRefPubMedGoogle Scholar
  79. 79.
    Van Wyk JJ, Ritzen EM (2003) The role of bilateral adrenal-ectomy in the treatment of congenital adrenal hyperplasia. J Clin Endocrinol Metab 88:2993–8CrossRefPubMedGoogle Scholar
  80. 80.
    Miccoli P, Iacconi P, Conte M, Goletti O, Buccianti P (1995) Laparoscopic adrenalectomy. J Laparoendosc Surg 5:221–6PubMedGoogle Scholar
  81. 81.
    Prinz RA (1995) A comparison of laparoscopic and open adrenalectomies. Arch Surg 130:489–92PubMedGoogle Scholar
  82. 82.
    Godellas CV, Prinz RA (1998) Surgical approach to adrenal neoplasms: laparoscopic versus open adrenalectomy. Surg Oncol Clin N Am 7:807–17PubMedGoogle Scholar
  83. 83.
    Wells SA, Merke DP, Cutler GB Jr, Norton JA, Lacroix A (1998) Therapeutic controversy: The role of laparoscopic surgery in adrenal disease. J Clin Endocrinol Metab 83:3041–9CrossRefPubMedGoogle Scholar
  84. 84.
    Janowski A (1977) Naturally occurring adrenal steroids with salt losing properties; relationship to congenital adrenal hyperplasia. In: Lee P, Plotnick L, Kowarski AA, Migeon C (eds) Congenital adrenal hyperplasia. University Park Press, Baltimore, pp 99–112Google Scholar
  85. 85.
    Gunther DF, Bukowski TP, Ritzen EM, Wedell A, Van Wyk JJ (1997) Prophylactic adrenalectomy of a three-year-old girl with congenital adrenal hyperplasia: pre-and postoperative studies. J Clin Endocrinol Metab 82: 3324–7CrossRefPubMedGoogle Scholar
  86. 86.
    Jara-Albarran A, Bayort J, Caballero A, Portillo J, Laborda L, Sampedro M, Cure C, Mateos JM (1979) Probable pituitary adenoma with adrenocorticotropin hypersecretion (corticotropinoma) secondary to Addison’s disease. J Clin Endocrinol Metab 49:236–41PubMedGoogle Scholar
  87. 87.
    Yanase T, Sekiya K, Ando M, Nawata H, Kato K, Ibayashi H (1985) Probable ACTH-secreting pituitary tumour in association with Addison’s disease. Acta Endocrinol (Copenh) 110:36–41PubMedGoogle Scholar
  88. 88.
    Carr DB, Fisher JE, Rosenblatt M (1986) Response to low-dose pulsatile cortisol in Addison’s disease with suspected corticotropinoma. Horm Metab Res 18:569–73PubMedGoogle Scholar
  89. 89.
    Karl M, Lamberts SW, Koper JW, Katz DA, Huizenga NE, Kino T, Haddad BR, Hughes MR, Chrousos GP (1996) Cushing’s disease preceded by generalized glucocorticoid resistance: clinical consequences of a novel, dominantnegative glucocorticoid receptor mutation. Proc Assoc Am Physicians 108:296–307PubMedGoogle Scholar
  90. 90.
    Horrocks PM, Franks S, Hockley AD, Rolfe EB, Van Noorden S, London DR (1982) An ACTH-secreting pituitary tumour arising in a patient with congenital adrenal hyperplasia. Clin Endocrinol (Oxf) 17:457–68Google Scholar
  91. 91.
    Newman K, Randolph J, Parson S (1992) Functional results in young women having clitoral reconstruction as infants. J Pediatr Surg 27:180–183; discussion 183–184CrossRefPubMedGoogle Scholar
  92. 92.
    Powell DM, Newman KD, Randolph J (1995) A proposed classification of vaginal anomalies and their surgical correction. J Pediatr Surg 30:271–275; discussion 275–276CrossRefPubMedGoogle Scholar
  93. 93.
    Alizai NK, Thomas DF, Lilford RJ, Batchelor AG, Johnson N (1999) Feminizing genitoplasty for congenital adrenal hyperplasia: what happens at puberty? J Urol 161:1588–1591CrossRefPubMedGoogle Scholar
  94. 94.
    Schnitzer JJ, Donahoe PK (2001) Surgical treatment of congenital adrenal hyperplasia. Endocrinol Metab Clin North Am 30:137–154PubMedGoogle Scholar
  95. 95.
    New MI, Carlson A, Obeid J, Marshall I, Cabrera MS, Goseco A, Lin-Su K, Putnam AS, Wei JQ, Wilson RC (2001) Prenatal diagnosis for congenital adrenal hyperplasia in 532 pregnancies. J Clin Endocrinol Metab 86:5651–5657CrossRefPubMedGoogle Scholar
  96. 96.
    Seckl JR, Miller WL (1997) How safe is long-term prenatal glucocorticoid treatment? JAMA 277:1077–1079CrossRefPubMedGoogle Scholar
  97. 97.
    Newnham JP (2001) Is prenatal glucocorticoid administration another origin of adult disease? Clin Exp Pharmacol Physiol 28:957–961CrossRefPubMedGoogle Scholar
  98. 98.
    Pang S, Clark AT, Freeman LC, Dolan LM, Immken L, Mueller OT, Stiff D, Shulman DI (1992) Maternal side effects of prenatal dexamethasone therapy for fetal congenital adrenal hyperplasia. J Clin Endocrinol Metab 75:249–253CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Authors and Affiliations

  • Evangelia Charmandari
  • George Chrousos
  • Deborah P. Merke

There are no affiliations available

Personalised recommendations